These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27018372)

  • 1. Evaluation of interleukin-6 and serotonin as biomarkers to predict response to fluoxetine.
    Manoharan A; Rajkumar RP; Shewade DG; Sundaram R; Muthuramalingam A; Paul A
    Hum Psychopharmacol; 2016 May; 31(3):178-84. PubMed ID: 27018372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.
    Amitai M; Taler M; Carmel M; Michaelovsky E; Eilat T; Yablonski M; Orpaz N; Chen A; Apter A; Weizman A; Fennig S
    J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):727-732. PubMed ID: 26771135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma serotonin level after 1 day of fluoxetine treatment: a biological predictor for antidepressant response?
    Alvarez JC; Gluck N; Fallet A; Grégoire A; Chevalier JF; Advenier C; Spreux-Varoquaux O
    Psychopharmacology (Berl); 1999 Mar; 143(1):97-101. PubMed ID: 10227085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
    Manoharan A; Shewade DG; Rajkumar RP; Adithan S
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma serotonin levels are associated with antidepressant response to SSRIs.
    Holck A; Wolkowitz OM; Mellon SH; Reus VI; Nelson JC; Westrin Å; Lindqvist D
    J Affect Disord; 2019 May; 250():65-70. PubMed ID: 30831543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
    Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Atake K; Nakamura J
    Hum Psychopharmacol; 2013 Sep; 28(5):466-70. PubMed ID: 23813968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fluoxetine concentrations and clinical improvement in an adolescent sample diagnosed with major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder.
    Blázquez A; Mas S; Plana MT; Gassó P; Méndez I; Torra M; Arnaiz JA; Lafuente A; Lázaro L
    J Clin Psychopharmacol; 2014 Jun; 34(3):318-26. PubMed ID: 24743718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Study Between Serotonin Transporter Gene and Fluoxetine Response in Mexican Patients With Major Depressive Disorder.
    Camarena B; Álvarez-Icaza D; Hernández S; Aguilar A; Münch L; Martínez C; Becerra-Palars C
    Clin Neuropharmacol; 2019; 42(1):9-13. PubMed ID: 30520759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rest-activity biomarker to predict response to SSRIs in major depressive disorder.
    McCall WV
    J Psychiatr Res; 2015 May; 64():19-22. PubMed ID: 25782717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
    Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD
    Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine.
    Hunter AM; Cook IA; Greenwald SD; Tran ML; Miyamoto KN; Leuchter AF
    J Clin Neurophysiol; 2011 Oct; 28(5):478-82. PubMed ID: 21946361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.
    Hale A; Corral RM; Mencacci C; Ruiz JS; Severo CA; Gentil V
    Int Clin Psychopharmacol; 2010 Nov; 25(6):305-14. PubMed ID: 20856123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.
    Ninan PT; Hassman HA; Glass SJ; McManus FC
    J Clin Psychiatry; 2004 Mar; 65(3):414-20. PubMed ID: 15096082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
    Egami M; Imamura Y; Nabeta H; Mizoguchi Y; Yamada S
    Hum Psychopharmacol; 2013 Jan; 28(1):7-14. PubMed ID: 23124792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients.
    Wang HC; Yeh TL; Chang HH; Gean PW; Chi MH; Yang YK; Lu RB; Chen PS
    Psychopharmacology (Berl); 2011 Feb; 213(4):773-9. PubMed ID: 20945066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Response to serotonergic and noradrenergic antidepressants: a crossover study of fluoxetine and desipramine in patients with first major depression episode].
    Ontiveros-Sánchez de la Barquera JA
    Gac Med Mex; 2017; 153(6):688-694. PubMed ID: 29206826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Markers Profile in Older Adolescents During Treatment with Selective Serotonin Reuptake Inhibitors.
    Martins LB; Delevati Colpo G; Calarge CA; Teixeira AL
    J Child Adolesc Psychopharmacol; 2021 Aug; 31(6):439-444. PubMed ID: 34166063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.